• Logo
  • SBMUJournals

Effect of Low-Level Laser Therapy in Treatment of Chemotherapy Induced Oral Mucositis

Soheir Shehata Samaan, Heba Mohamed Abd Elshafi, Reem Jan Farid, Mohamed Abd Elrahman Hassan, Samy Ahmed Alsirafy
353

Views

PDF

Abstract

Introduction: Oral mucositis (OM) is an unavoidable condition of the oral cavity that accompanies chemotherapy for various malignant cases. Chemotherapy-induced oral Mucositis (COM) is a frequent complication due to mucotoxic drugs and is known to deteriorate the general health significantly, while negatively affecting the quality of life (QOL). Studies have reported that low-level laser therapy (LLLT) promotes the tissue healing. The objective of the present study was to explore the efficacy of gallium-arsenide (GaAs) laser in treating COM and its impact on inflammatory cytokine levels in patients receiving chemotherapy for various malignancies.
Methods: A total of 80 patients with COM received LLLT 6 days/week. OM was graded according to the World Health Organization (WHO) grading scale. The outcome parameters were the serum levels of tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) measured before, during and after administration of LLLT.
Results: After LLLT, a significant decrease was found in the mean values of mucositis grade from 2.35 ± 0.695 to 1.13 ± 0.333 after (P < 0.001). A significant reduction in the level of TNF-α was found after LLLT among breast cancer patients (P = 0.0045), but not in head and neck cancer and lymphoma patients. A significant reduction was also found in IL-6 level after treatment among head and neck and breast cancer patients (P = 0.0307 and 0.019, respectively).
Conclusion: The use of GaAs LLLT in treating COM in patients with various malignancies is well tolerated by patients, it results in improvement of mucositis, however; mechanism of action does not seem to be completely linked to the change of pro or anti-inflammatory cytokines.

Keywords

Low-level laser therapy; Oral Mucositis; Cancer.

References

P. Laser parameters drawn from meta-analysis on the efficacy of LLLT in oral mucositis. Support Care Cancer. 2012; 20(1):1-283. doi:10.1007/s00520-011-1202-0

Campos MI, Campos CN, Aarestrup FM, Aarestrup BJ. Oral mucositis in cancer treatment:Natural history, prevention and treatment. Mol Clin Oncol. 2014;2(3):337- 40. doi:10.3892/mco.2014.253

Jones JA, Avritscher EB, Cooksley CD, Michelet M, Bekele BN, Elting LS. Epidemiology of treatment-associated mucosal injury after treatment with newer regimens for lymphoma, breast, lung, or colorectal cancer. Support Care Cancer. 2006;14(6):505-15. doi:10.1007/s00520-006-0055- 4

Vigarios E, Epstein JB, Sibaud V. Oral mucosal changes induced by anticancer targeted therapies and immune checkpoint inhibitors. Support Care Cancer. 2017;25(5):1713-9. doi:10.1007/s00520-017-3629-4

Bonomi M. and Batt K. Supportive management of mucositis and metabolic derangements in head and neck cancer patients. Cancers (Basel). 2015;7:1743-57. doi:10.3390/cancers7030862

Gholizadeh N, Sheykhbahaei N, Sadrzadeh-Afshar M. New treatment approaches of oral mucositis: a review of literature. Adv Hum Biol. 2016;6:66-72. doi:10.4103/2321- 8568.190319

Lalla RV, Saunders DP, Peterson DE. Chemotherapy or radiation-induced oral mucositis. Dent Clin North Am. 2014;58(2):341-9. doi:10.1016/j.cden.2013.12.005

Barkokebas A, Silva IH, de Andrade SC, et al. Impact of oral mucositis on oral-health-related quality of life of patients diagnosed with cancer. J Oral Pathol Med. 2015;44(9):746- 51. doi:10.1111/jop.12282

Gobbo M, Ottaviani G, Perinetti G, et al. Evaluation of nutritional status in head and neck radio-treated patients affected by oral mucositis: efficacy of class IV laser therapy. Support Care Cancer. 2014;22(7):1851-1856. doi: 10.1007/ s00520-014-2155-x.

Lalla RV, Bowen J, Barasch A, et al. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy. Cancer. 2014;120(10):1453- 61. doi:10.1002/cncr.28592

Chaveli-López B, Bagán-Sebastián JV. Treatment of oral mucositis due to chemotherapy. J Clin Exp Dent. 2016;8(2):e201-e209. doi:10.4317/jced.52917

Antunes H, Herchenhorn D, Small I, et al. Phase III trial of low-level laser therapy to prevent oral mucositis in head and neck cancer patients treated with concurrent chemoradiation. Radiother Oncol. 2013;109:297-302.

Robijns J, Censabella S, Bulens P, Maes A, Mebis J. The use of low-level light therapy in supportive care for patients with breast cancer: review of the literature. Lasers Med Sci. 2017;32(1):229-42. doi:10.1007/s10103-016-2056-y

Fekrazad R, Chiniforush N. Oral mucositis prevention and management by therapeutic laser in head and neck cancers. J Lasers Med Sci. 2014;5(1):1-7.

Figueiredo A, Lins L, Cattony A, Falcão A. Laser therapy in the control of oral mucositis:a meta-analysis. Rev Assoc Med Bras (1992). 2013;59(5):467-474. doi:10.1016/j. ramb.2013.08.003

Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L. Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One. 2014;9(9):e107418. doi:10.1371/journal. pone.0107418

World Health Organization. Handbook for reporting results of cancer treatment. Genava: World Health Organization; 1979:15-22.

Lanz B, Kostamovaara JT. Current pulse investigation toward optimal pumping of a gain-switched asymmetric waveguide laser diode. Proceedings of SPIE Laser Technology for Defense and Security X Conference (DSS); Baltimore, USA; 5– 9 May 2014: 90810W 1–10.

Arbabi-Kalati F, Arbabi-Kalati F, Moridi T. Evaluation of the effect of low level laser on prevention of chemotherapy-induced mucositis. Acta Med Iran. 2013;51(3):157-162.

Ahmed KM, Hussein SA, Noori AJ, Abdulateef SN, Abdulla BK. Evaluation of low level laser therapy in the management of chemotherapy-induced oral mucositis in pediatric and young cancer patients: a randomized clinical trial. European Scientific Journal. 2015;11(27):209-222.

Amadori F, Bardellini E, Conti G, Pedrini N, Schumacher RF, Majorana A. Low-level laser therapy for treatment of chemotherapy-induced oral mucositis in childhood: a randomized double-blind controlled study. Lasers Med Sci. 2016;31(6):1231-1236.

Ahad A, Tasneem S, Lamba AK, Khan S. Healing of self-inflicted thermal injury of palatal mucosa by low level laser therapy. Spec Care Dentist. 2017;37(6):314-317. doi:10.1111/scd.12256

Logan RM, Stringer AM, Bowen JM, et al. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: pathobiology, animal models and cytotoxic drugs. Cancer Treat Rev. 2007;33(5):448- 460. doi:10.1016/j.ctrv.2007.03.001

Raber-Durlacher JE, von Bültzingslöwen I, Logan RM, et al. Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer. 2013;21(1):343-355. doi:10.1007/ s00520-012-1594-5

Silva GB, Sacono NT, Othon-Leite AF, et al. Effect of low-level laser therapy on inflammatory mediator release during chemotherapy-induced oral mucositis: a randomized preliminary study. Lasers Med Sci. 2015;30(1):117-126. doi:10.1007/s10103-014-1624-2

Usuda J, Okunaka T, Furukawa K, et al. Increased cytotoxic effects of photodynamic therapy in IL‐6 gene transfected cells via enhanced apoptosis. IJC. 2001;39(4):475-80.

de Paula Eduardo F, Bezinelli LM, da Graça Lopes RM, Nascimento Sobrinho JJ, Hamerschlak N, Correa L. Efficacy of cryotherapy associated with laser therapy for decreasing severity of melphalan-induced oral mucositis during hematological stem-cell transplantation:a prospective clinical study. Hematol Oncol. 2015;33(3):152- 158. doi:10.1002/hon.2133

Medeiros-Filho JB, Maia Filho EM, Ferreira MC. Laser and photochemotherapy for the treatment of oral mucositis in young patients: randomized clinical trial. Photodiagnosis Photodyn Ther. 2017;18:39-45. doi:10.1016/j. pdpdt.2017.01.004




DOI: https://doi.org/10.22037/jlms.v10i2.19015